Open AccessRethinking the Accelerated Approval Pathway at the FDA
Author(s) -
Peggy Eastman
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000725536.79564.52
Subject(s) - food and drug administration , medicine , approved drug , drug development , clinical trial , drug approval , white paper , expanded access , clinical research , covid-19 , flexibility (engineering) , pandemic , cancer drugs , drug , pharmacology , oncology , political science , management , law , disease , infectious disease (medical specialty) , economics